Skip to main content

Table 1 Matching criteria of male and female breast cancer patients

From: Matched-pair analysis of patients with female and male breast cancer: a comparative analysis

 

Men

 

Women

 

Χ2

Median age (range)

67 (43-89)

 

67 (36-89)

  

< 49

9

8.3%

8

7.4%

0.98

50-59

12

11.1%

13

12.0%

 

60-69

42

38.9%

40

37.0%

 

70-79

30

27.8%

31

28.7%

 

> 80

15

13.9%

16

14.8%

 

Tumor Stage pTis

4

3, 7%

4

3.8%

0.91

pT1

37

35.6%

36

34.6%

 

pT2

32

30.8%

37

35.6%

 

pT3

5

4.8%

4

3.8%

 

pT4

26

25.0%

23

22.1%

 

Nodal Stage pN0

57

56.4%

56

56.0%

0.85

pN+

44

43.6%

44

44.0%

 

Grading G1

7

6.5%

6

6.1%

0.93

G2

62

63.3%

62

62.6%

 

G3

29

29.6%

31

31.3%

 

ER-expression ER-

19

17.6%

19

17.6%

1.0

ER+

71

65.7%

72

66.7%

 

unknown

18

16.7%

17

15.7%

 

PR-expression PR-

21

19.4%

22

20.4%

0.86

PR+

69

63.9%

69

63.9%

 

unknown

18

16.7%

17

15.7%

 

HR-expression HR+

78

72.2%

77

71.3%

0.84

HR-

13

12.1%

14

13.0%

 

unknown

17

15.7%

17

14.7%

 

HER2 HER 2 -

70

64.8%

63

58.3%

0.36

HER 2 +

7

6.5%

10

9.3%

 

unknown

31

28.7%

35

32.4%

 
  1. Chi-Quadrat test (X2) was calculated in order to demonstrate accordance between male and female matching parameters.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us